Curious about today's AI digest?ai-tldr.dev
Pomegra LogoPomegra

Daily Digest

BriefMarket · mixedMedium impact
Esc

Oscar Health Stock Rises 2% on Raised 2026 Earnings Guidance

SEC / Oscar Health2 min read6 sources

Why is Oscar Health stock up today?

Oscar Health (OSCR) stock rose 2% on Thursday after the ACA insurer raised its 2026 earnings guidance by $100 million to $600M–$800M at its Investor Day, spurring two analyst price-target hikes.

Key numbers

2026 Earnings from Operations Guidance$600M–$800M+$100M vs prior $500M–$700M guidance
Medical Loss Ratio Target81.0%–82.0%–50bp vs prior 81.5%–82.5% target
2026 Revenue Guidance$18.7B–$19.0BReaffirmed — no change
Q2 2026 Earnings from Operations$389M+$590M YoY net income swing
OSCR Stock YTD Performance+109%vs +12.5% for healthcare sector
ACA Members (June 30, 2026)2.96M+46% year-over-year

What happened

Oscar Health (OSCR) stock rose 2% on Thursday after the ACA insurer raised its 2026 earnings guidance by $100 million to $600M–$800M at its Investor Day, spurring two analyst price-target hikes. The company also said it now expects to spend 81.0%–82.0% of each premium dollar on patient care — a 50-basis-point improvement from its prior medical loss ratio target — signaling that the steep premium increases Oscar charged heading into 2026 are paying off. Barclays analyst Andrew Mok raised his price target to $49 from $39 while Piper Sandler's Jessica Tassan reiterated a $48 target, both citing Oscar's position as the only large insurer focused entirely on the ACA marketplace. Oscar's stock has gained 109% year-to-date, reversing a $396 million operating loss from full-year 2025.

Why it matters

Oscar Health is the only major insurer that relies almost entirely on the Affordable Care Act marketplace, making its results a direct signal of whether ACA health plans can be sustainably profitable — something every insurer weighing the market watches closely. The guidance raise shows that the repricing Oscar pushed through into 2026 is holding: fewer unexpectedly large medical bills are arriving than the company feared, and it is keeping more of each premium dollar as profit. In a week when most healthcare stocks were being dragged lower by broader market worries, that is a rare and unusually bright spot.

Who this affects

Marketmixed
Medium impact
Healthcare sector broadly down this week; OSCR outperforms on guidance beat.
Companybullish
High impact
Oscar shareholders benefit; stock up 109% YTD on sharp turnaround.
Competitorsbearish
Low impact
Centene, Molina face stronger ACA rival with tighter medical costs.
Industrybullish
Low impact
ACA repricing discipline paying off; early signal of sector margin recovery.

Oscar Health vs Centene, Molina Healthcare

Oscar HealthOSCR:NYSE$9.8B+2%+109%18x
CenteneCNC:NYSE$32.5B-1.9%+60%12x
Molina HealthcareMOH:NYSE$10.6B-0.9%+17%20x

As of 2026-09-18

How we got here

  1. Q1 2026 record quarterly profit; stock +10.7%; guidance reaffirmed

  2. Q2 results; EfO guidance raised $250M to $500M–$700M range

  3. Investor Day 8-K; EfO raised $100M to $600M–$800M; MLR tightened 50bp

  4. Barclays lifts PT to $49 from $39; Piper Sandler reiterates $48; stock +2%

  5. Raymond James raises PT to $42 from $34; stock retreats 0.3%

What to watch

  • ACA open enrollment starts Nov 1; early volumes signal 2027 membership outlook2026-11-01
  • Q3 2026 earnings; MLR will confirm or undermine the raised full-year guidanceQ4 2026
  • Congressional ACA subsidy vote; expiry could trigger membership attrition for OscarQ4 2026

Educational content only. Not investment advice.

More briefsAll briefs →